April 29, 2025 11:37 AM EDTUpdated 03:10 PM
Manufacturing

Mer­ck plans to bring Keytru­da pro­duc­tion to the US with $1B bi­o­log­ics fac­to­ry

Anna Brown

News Reporter

Mer­ck is shift­ing man­u­fac­tur­ing for its block­buster drug Keytru­da to a new $1 bil­lion fac­to­ry in Delaware, dou­bling down on its plans to move pro­duc­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

FDA de­lays PDU­FA date for small biotech, rais­ing ques­tions about im­pact of agency cuts

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

With a new CEO, oligonu­cleotide biotech Crey­on forges Eli Lil­ly part­ner­ship

Oc­ta­gon Ther­a­peu­tics shuts down af­ter 'un­re­solved bi­ol­o­gy ques­tion­s'

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times